Cargando…

Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity.

Detalles Bibliográficos
Autores principales:	Tank, B., Marquet, R. L., Weimar, W., Westbroek, D. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1984
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976876/ https://www.ncbi.nlm.nih.gov/pubmed/6466539

Ejemplares similares

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.
por: Ravaud, A., et al.
Publicado: (1994)

Intraventricular recombinant alpha-interferon in subacute sclerosing panencephalitis
por: Cianchetti, C., et al.
Publicado: (1991)

Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma.
por: Hersey, P., et al.
Publicado: (1985)

The influence of Escherichia coli cultivation temperature on interferon alpha 2a expression (IFN-α2a)
por: Arthuso, Fernanda dos Santos, et al.
Publicado: (2014)

Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha/Lambda Inhibition
por: Sur, Debpali, et al.
Publicado: (2022)

Impact of Interferon-alpha1b (IFN-α1b) on Antitumor Immune Response: An Interpretation of the Promising Therapeutic Effect of IFN-alpha1b on Melanoma
por: Liu, Yu, et al.
Publicado: (2020)

Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension
por: Bauer, Eileen M., et al.
Publicado: (2014)

Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
por: Gull, Iram, et al.
Publicado: (2013)

Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia
por: Ghaffari, Reza, et al.
Publicado: (2021)

EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary Group.
por: De Mulder, P. H., et al.
Publicado: (1995)

Protection of Hepatocytes from Cytotoxic T Cell Mediated Killing by Interferon-Alpha
por: Willberg, Christian B., et al.
Publicado: (2007)

Recombinant DNA human interferon alpha 2 in advanced breast cancer: a phase 2 trial.
por: Padmanabhan, N., et al.
Publicado: (1985)

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.
por: Lai, C. L., et al.
Publicado: (1989)

The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
por: Bergsagel, D. E., et al.
Publicado: (1990)

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
por: Biesma, B., et al.
Publicado: (1992)

Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies
por: Ali Khan, Wahid
Publicado: (2018)

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells
Publicado: (1993)

Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.
por: Pichert, G., et al.
Publicado: (1990)

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.
por: Johnston, S. R., et al.
Publicado: (1998)

Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection
por: Carreca, Anna Paola, et al.
Publicado: (2022)

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1990)

Varicella-zoster virus Neurovasculitis (VZV-NV) in the Setting of Autoantibodies to Interferon alpha (anti-IFNα)
por: Ansari, Rahila, et al.
Publicado: (2017)

Acute and Sub-chronic Toxicity Study of Recombinant Bovine Interferon Alpha in Rodents
por: Yu, Hai-Yang, et al.
Publicado: (2021)

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma.
por: Kruit, W. H., et al.
Publicado: (1996)

Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma
por: Furuya, Nobutaka, et al.
Publicado: (2011)

Interferons Alpha, Beta, and Omega
por: Meager, Anthony
Publicado: (1998)

Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses
por: Hwang, Mihyun, et al.
Publicado: (2018)

Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice
por: Ravaud, A, et al.
Publicado: (1999)

Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects
por: Yi, Taolin, et al.
Publicado: (2011)

Lack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics.
por: Seymour, M. T., et al.
Publicado: (1994)

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1992)

Intratumoral recombinant human interferon alpha‐2a and vincristine combination therapy in canine transmissible venereal tumour
por: Kanca, Halit, et al.
Publicado: (2018)

Immunological effects of alternative weekly interferon-alpha-2b and low dose interleukin-2 in patients with cancer.
por: Fiorentino, B., et al.
Publicado: (1992)

Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study
por: Wang, Bo, et al.
Publicado: (2020)

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
por: Keshvari, Maryam, et al.
Publicado: (2014)

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma
por: Suarez-Kelly, Lorena P., et al.
Publicado: (2019)

Alpha 2 mu, alpha 2u, or alpha 2u.
por: Witschi, H
Publicado: (1997)

Natural killer (NK) activity and interferon (IFN) production by a fraction of spleen and blood lymphocytes in swine
por: Salmon, H., et al.
Publicado: (1989)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
por: Wittling, Megen C., et al.
Publicado: (2021)

Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_037qrtuouoq3h48md87kof9auq